Diabetic Retinopathy Tied to Lower Vision-Related Quality of Life
TUESDAY, Feb. 6, 2024 -- Vision-related quality of life (VRQoL) declines with the presence and higher severity of diabetic retinopathy (DR), according to a review published online Feb. 1 in JAMA Ophthalmology.
Mohammed G. Zayed, from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 6, 2024 Category: Pharmaceuticals Source Type: news
Diagnosed With Macular Degeneration? Here's What You Need to Know
TUESDAY, Feb. 6, 2024 -- Age-related macular degeneration can lead to vision loss in seniors, but new therapies have offered fresh hope for preserving eyesight later in life, eye experts say.These cutting-edge therapies benefit both the dry and wet... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 6, 2024 Category: General Medicine Source Type: news
iFixit broke open the $3,500 Apple Vision Pro to see what's inside
The Apple Vision Pro launched in the US on February 2. Justin Sullivan/Getty Images Want to know what's inside the Apple Vision Pro but don't want to break yours open? Understandable. iFixit published a video that'll give you just that. Check out their inside look at the headset's hardware. The…#applevisionpro #ifixit #eyesight #understandably #visionpro (Source: Reuters: Health)
Source: Reuters: Health - February 5, 2024 Category: Consumer Health News Source Type: news
OCLI Vision Welcomes Dr. Kinnari Patel, OD, to the Northeast Philadelphia, Pennsylvania Area to Expand Access to Great Eye Care in the Region
OCLI Vision is excited to welcome Dr. Kinnari Patel, OD, to their team, exclusively serving the Northeast Philadelphia location starting February 5th, 2024. Dr. Patel, a highly accomplished optometrist, brings over a decade of experience and expertise in primary eye care. GARDEN CITY, N.Y.... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 5, 2024 Category: Pharmaceuticals Tags: PER Source Type: news
SightMD Pennsylvania Welcomes David L. Silverman, MD to its Expert Team
SightMD PA, a leading multi-specialty ophthalmology platform in Pennsylvania, welcomes David L. Silverman, MD to its expert team. HAUPPAUGE, N.Y., Feb. 5, 2024 /PRNewswire-PRWeb/ -- SightMD PA, a leading multi-specialty ophthalmology platform in Pennsylvania, welcomes David L. Silverman,... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 5, 2024 Category: Pharmaceuticals Tags: PER Source Type: news
February Frenzy: These 5 Cryptos Have Nearly $1 Billion Worth of Unlocks Due This Month
The crypto market is poised for increased selling pressure across numerous tokens as unlocks worth nearly $1 billion are set to occur this month. Projects such as Optimism (OP), Avalanche (AVAX), The Sandbox (SAND), Aptos (APT), and Sui (SUI) are expected to have the largest unlocks, adding to the…#optimism #sand #apt #sandbox #optokens #coinmarketcap #dydx (Source: Reuters: Health)
Source: Reuters: Health - February 5, 2024 Category: Consumer Health News Source Type: news
Medic issues measles warning - some children may risk 'life changing complications'
This highly contagious disease can lead to pneumonia, meningitis, blindness and seizures. (Source: Daily Express - Health)
Source: Daily Express - Health - February 5, 2024 Category: Consumer Health News Source Type: news
Living near nature is good for kids' eyesight - as scientists fear too much screen time, not enough time outdoors and POLLUTION makes them need glasses
The scientists looked at data on 286,801 children aged seven to 12 in Guangzhou, a city in China with 18million inhabitants - testing them over three years. (Source: the Mail online | Health)
Source: the Mail online | Health - February 5, 2024 Category: Consumer Health News Source Type: news
Vision Pro Teardown
The strangest thing about the Vision Pro is also the thing that makes it most uniquely Apple: it’s got a big shiny bubble glass front, which makes it stand out from the aluminum- and plastic-shrouded competition, even when it’s off. And when it’s on, it’s even stranger—instead of being fully…#visionpro #apple #eyesight #creepy #vr #torx #ifixit #samgoldheart #soloknitband #sim (Source: Reuters: Health)
Source: Reuters: Health - February 4, 2024 Category: Consumer Health News Source Type: news
Cure Herpetic Stromal Keratitis With CRISPR
One of the most severe complications of HSV is herpetic stromal keratitis (HSK), which affects the cornea of the eye and can lead to visual impairment or even blindness. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 2, 2024 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news
Specsavers Ad Shows What Can Go Wrong Without Glasses in an Airport
Getting through a busy airport can be stressful at the best of times, but it can be even more problematic when your eyesight lets you down, as optical retailer Specsavers relays in its latest humorous campaign. Set to run for eight weeks in the U.K. from Feb. 2, the minutelong TV spot, "Airport,"…#specsavers (Source: Reuters: Health)
Source: Reuters: Health - February 2, 2024 Category: Consumer Health News Source Type: news
Ocular trauma among patients visiting the outpatient department of ophthalmology in a tertiary care centre - Basnet A, Dhakal G, Ghising K, Pathak SB, Shrestha T.
INTRODUCTION: Ocular trauma is an important cause of blindness and ocular morbidity worldwide. Knowledge of the cause of eye injuries can guide preventive strategies and optimize management capacity. The aim of the study was to find out the prevalence of o... (Source: SafetyLit)
Source: SafetyLit - February 1, 2024 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
New long-term data for Roche ’s Vabysmo show sustained retinal drying and vision improvements in retinal vein occlusion (RVO)
Vabysmo sustained robust drying of retinal fluid, often associated with distorted or blurry visionUp to 60% of people receiving Vabysmo were able to extend treatment intervals to three or four months apartDetailed results from two global Phase III RVO studies will be presented at Angiogenesis, Exudation, and Degeneration 2024Vabysmo is approved in the US for RVO, and in more than 90 countries around the world for people living with nAMD and DMEBasel, 1 February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new 72-week data from two global Phase III studies, BALATON and COMINO, evaluating Vabysmo® (faricimab) i...
Source: Roche Investor Update - February 1, 2024 Category: Pharmaceuticals Source Type: news
New long-term data for Roche ’s Vabysmo show sustained retinal drying and vision improvements in retinal vein occlusion (RVO)
Vabysmo sustained robust drying of retinal fluid, often associated with distorted or blurry visionUp to 60% of people receiving Vabysmo were able to extend treatment intervals to three or four months apartDetailed results from two global Phase III RVO studies will be presented at Angiogenesis, Exudation, and Degeneration 2024Vabysmo is approved in the US for RVO, and in more than 90 countries around the world for people living with nAMD and DMEBasel, 1 February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new 72-week data from two global Phase III studies, BALATON and COMINO, evaluating Vabysmo® (faricimab) i...
Source: Roche Media News - February 1, 2024 Category: Pharmaceuticals Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche exceeds guidance and achieves sales growth of 1% (CER) for 2023 despite sharp COVID-19 sales decline
Group salesgrow by 1%1 at constant exchange rates (CER; -7% in CHF), more than offsetting the decline in COVID-19-related sales and biosimilar erosion, and thereby exceeding 2023 guidanceExcluding COVID-19 products,Group sales increase by 8%Pharmaceuticals Divisionsalesincrease by 6% (excluding COVID-19 medicine Ronapreve: +9%) due to ongoing high demand for newer medicines, with eye medicine Vabysmo continuing to be the top growth driver, followed by Ocrevus (multiple sclerosis), Hemlibra (haemophilia A) and Polivy (blood cancer)Diagnostics Division salesare 13% lower due to high demand for COVID-19 tests in 2022; strong ...
Source: Roche Media News - February 1, 2024 Category: Pharmaceuticals Source Type: news
